Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) had its price target raised by research analysts at Barclays from $9.00 to $11.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s price objective suggests a potential upside of 13.55% from the stock’s […]